126 related articles for article (PubMed ID: 16707439)
1. Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma.
Ayala GE; Dai H; Tahir SA; Li R; Timme T; Ittmann M; Frolov A; Wheeler TM; Rowley D; Thompson TC
Cancer Res; 2006 May; 66(10):5159-64. PubMed ID: 16707439
[TBL] [Abstract][Full Text] [Related]
2. Growth and survival mechanisms associated with perineural invasion in prostate cancer.
Ayala GE; Dai H; Ittmann M; Li R; Powell M; Frolov A; Wheeler TM; Thompson TC; Rowley D
Cancer Res; 2004 Sep; 64(17):6082-90. PubMed ID: 15342391
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer.
Tahir SA; Yang G; Goltsov AA; Watanabe M; Tabata K; Addai J; Fattah el MA; Kadmon D; Thompson TC
Cancer Res; 2008 Feb; 68(3):731-9. PubMed ID: 18245473
[TBL] [Abstract][Full Text] [Related]
4. The sensitivity to beta-carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells.
Palozza P; Sestito R; Picci N; Lanza P; Monego G; Ranelletti FO
Carcinogenesis; 2008 Nov; 29(11):2153-61. PubMed ID: 18635524
[TBL] [Abstract][Full Text] [Related]
5. Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis.
Yang G; Addai J; Wheeler TM; Frolov A; Miles BJ; Kadmon D; Thompson TC
Hum Pathol; 2007 Nov; 38(11):1688-95. PubMed ID: 17707459
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.
Li L; Yang G; Ebara S; Satoh T; Nasu Y; Timme TL; Ren C; Wang J; Tahir SA; Thompson TC
Cancer Res; 2001 Jun; 61(11):4386-92. PubMed ID: 11389065
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
8. Bystin in perineural invasion of prostate cancer.
Ayala GE; Dai H; Li R; Ittmann M; Thompson TC; Rowley D; Wheeler TM
Prostate; 2006 Feb; 66(3):266-72. PubMed ID: 16245277
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
[TBL] [Abstract][Full Text] [Related]
10. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I.
Kawada M; Inoue H; Arakawa M; Ikeda D
Anticancer Res; 2008; 28(2A):721-30. PubMed ID: 18507013
[TBL] [Abstract][Full Text] [Related]
12. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
14. Mice with cav-1 gene disruption have benign stromal lesions and compromised epithelial differentiation.
Yang G; Timme TL; Naruishi K; Fujita T; Fattah el MA; Cao G; Rajagopalan K; Troung LD; Thompson TC
Exp Mol Pathol; 2008 Apr; 84(2):131-40. PubMed ID: 18358473
[TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.
Ifere GO; Barr E; Equan A; Gordon K; Singh UP; Chaudhary J; Igietseme JU; Ananaba GA
Cancer Detect Prev; 2009; 32(4):319-28. PubMed ID: 19186008
[TBL] [Abstract][Full Text] [Related]
17. Cancer-related axonogenesis and neurogenesis in prostate cancer.
Ayala GE; Dai H; Powell M; Li R; Ding Y; Wheeler TM; Shine D; Kadmon D; Thompson T; Miles BJ; Ittmann MM; Rowley D
Clin Cancer Res; 2008 Dec; 14(23):7593-603. PubMed ID: 19047084
[TBL] [Abstract][Full Text] [Related]
18. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
Turley RS; Finger EC; Hempel N; How T; Fields TA; Blobe GC
Cancer Res; 2007 Feb; 67(3):1090-8. PubMed ID: 17283142
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction.
Massoner P; Haag P; Seifarth C; Jurgeit A; Rogatsch H; Doppler W; Bartsch G; Klocker H
Prostate; 2008 Aug; 68(11):1165-78. PubMed ID: 18459102
[TBL] [Abstract][Full Text] [Related]
20. Biological significance of perineural invasion (PNI) in prostate cancer.
Fromont G; Godet J; Pires C; Yacoub M; Dore B; Irani J
Prostate; 2012 Apr; 72(5):542-8. PubMed ID: 21748758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
